-
公开(公告)号:JPH10279568A
公开(公告)日:1998-10-20
申请号:JP6266598
申请日:1998-03-13
Applicant: HOECHST AG
Inventor: FALK EUGEN , ENHSEN ALFONS , STENGELIN SIEGFRIED , GLOMBIK HEINER
IPC: C12N15/09 , A61K31/55 , A61K31/554 , A61K31/675 , A61K31/70 , A61K48/00 , A61P1/16 , A61P3/06 , A61P3/10 , A61P9/10 , A61P35/00 , C07D281/00 , C07D281/10 , C07D417/04 , C07D417/10 , C07D417/12 , C07F9/6558 , C07H17/00 , C12N5/00 , C12N5/10 , C12N9/12 , C12N15/06 , C12N15/10 , C12N15/11 , C12N15/54 , C12N15/85 , C12P21/02 , C12R1/91
Abstract: PROBLEM TO BE SOLVED: To obtain a new compound capable of reducing the concentration of an (ultra) low density lipoprotein cholesterol in plasma or serum and useful for treating and preventing hyperlipemia such as atherosclerosis. SOLUTION: This compound is represented by formula I R and R are each a straight-chain 1-6C alkyl; R is H or OR [R is H or a (substituted) 1-6C alkyl]; R is pyridyl or a (substituted) phenyl; R , R and R are each H, a halogen, cyano, etc.; R is represented by formula II (R is COOH, CH2 OH, etc.), etc.; X is NH or O; R and R are each H or 1-6C alkyl}. The objective compound is prepared by acylating or alkylating a compound represented by formula III at the group X-H according to the standard method or glycosylating or glucuronidating the compound represented by formula III at the group X-H and then eliminating the protecting group, especially hydroxyl group and amino functional group.
-
公开(公告)号:NO304653B1
公开(公告)日:1999-01-25
申请号:NO932159
申请日:1993-06-11
Applicant: HOECHST AG
Inventor: ENHSEN ALFONS , GLOMBIK HEINER , KRAMER WERNER , WESS G NTHER
Abstract: Bile acid derivatives of the formula I Z(X-GS)n in which GS, X, Z and n have the stated meanings, and a process for the production of these compounds are described. The compounds have pharmacological activity and can therefore be used as pharmaceuticals, in particular as hypolipidaemic.
-
公开(公告)号:HUT67574A
公开(公告)日:1995-04-28
申请号:HU9401408
申请日:1994-05-06
Applicant: HOECHST AG
Inventor: WESS GUENTHER , KRAMER WERNER , ENHSEN ALFONS , GLOMBIK HEINER
IPC: A61K31/575 , A61K31/58 , A61P3/06 , A61P9/10 , C07J9/00 , C07J31/00 , C07J41/00 , C07J43/00 , C07J51/00
Abstract: Monomeric bile acid derivatives of the formula I Z-X-GS I, in which GS, X and Z have the stated meanings, and processes for their preparation are described. The compounds have valuable pharmacological properties and can therefore be used as medicines.
-
公开(公告)号:AU6194994A
公开(公告)日:1994-11-10
申请号:AU6194994
申请日:1994-05-06
Applicant: HOECHST AG
Inventor: GLOMBIK HEINER , ENHSEN ALFONS , KRAMER WERNER , WESS GUNTHER
IPC: A61K31/575 , A61K31/58 , A61P3/06 , A61P9/10 , C07J9/00 , C07J31/00 , C07J41/00 , C07J43/00 , C07J51/00 , C07J17/00 , A61K31/565 , A61K31/66
Abstract: Monomeric bile acid derivatives of the formula I Z-X-GS I, in which GS, X and Z have the stated meanings, and processes for their preparation are described. The compounds have valuable pharmacological properties and can therefore be used as medicines.
-
公开(公告)号:AU6194694A
公开(公告)日:1994-11-10
申请号:AU6194694
申请日:1994-05-06
Applicant: HOECHST AG
Inventor: ENHSEN ALFONS , GLOMBIK HEINER , KRAMER WERNER , WESS GUNTHER
IPC: A61K31/575 , A61P3/06 , A61P9/00 , C07J3/00 , C07J7/00 , C07J9/00 , C07J31/00 , C07J41/00 , C07J51/00
Abstract: nor-Bile acid derivatives of the formula I G1 - X - G2 I, in which G1, G2 and X have the stated meanings, processes for preparing these compounds and medicines are described. On the basis of their pharmacological action, they can be used as antihyperlipidaemic.
-
公开(公告)号:NO941678L
公开(公告)日:1994-11-09
申请号:NO941678
申请日:1994-05-06
Applicant: HOECHST AG
Inventor: ENHSEN ALFONS , GLOMBIK HEINER , KRAMER WERNER , WESS GUNTHER
IPC: A61P3/06 , A61P9/00 , A61K31/575 , C07J3/00 , C07J7/00 , C07J9/00 , C07J31/00 , C07J41/00 , C07J51/00
Abstract: nor-Bile acid derivatives of the formula I G1 - X - G2 I, in which G1, G2 and X have the stated meanings, processes for preparing these compounds and medicines are described. On the basis of their pharmacological action, they can be used as antihyperlipidaemic.
-
公开(公告)号:NO941677L
公开(公告)日:1994-11-09
申请号:NO941677
申请日:1994-05-06
Applicant: HOECHST AG
Inventor: ENHSEN ALFONS , GLOMBIK HEINER , KRAMER WERNER , WESS GUNTHER
IPC: A61K31/575 , A61K31/58 , A61K31/675 , A61P3/06 , A61P9/10 , C07J9/00 , C07J17/00 , C07J41/00 , C07J43/00
Abstract: Tetrazole bile acid derivatives of the formula I G1 - X - G2 I in which G1, G2 and X have the stated meanings, and processes for their preparation are described. The compounds have valuable pharmacological properties and can therefore be used as medicines.
-
公开(公告)号:NO941677A
公开(公告)日:1994-11-09
申请号:NO941677
申请日:1994-05-06
Applicant: HOECHST AG
Inventor: ENHSEN ALFONS , GLOMBIK HEINER , KRAMER WERNER , WESS GUNTHER
IPC: A61K31/575 , A61K31/58 , A61K31/675 , A61P3/06 , A61P9/10 , C07J9/00 , C07J17/00 , C07J41/00 , C07J43/00
CPC classification number: C07J9/005 , C07J17/00 , C07J41/0005 , C07J41/0094 , C07J43/003
-
公开(公告)号:FI942077A
公开(公告)日:1994-11-09
申请号:FI942077
申请日:1994-05-05
Applicant: HOECHST AG
Inventor: GLOMBIK HEINER , ENHSEN ALFONS , KRAMER WERNER , WESS GUENTHER
IPC: A61K31/575 , A61K31/58 , A61P3/06 , A61P9/10 , C07J9/00 , C07J31/00 , C07J41/00 , C07J43/00 , C07J51/00 , C07J17/00
Abstract: Monomeric bile acid derivatives of the formula I Z-X-GS I, in which GS, X and Z have the stated meanings, and processes for their preparation are described. The compounds have valuable pharmacological properties and can therefore be used as medicines.
-
10.
公开(公告)号:CA2123051A1
公开(公告)日:1994-11-09
申请号:CA2123051
申请日:1994-05-06
Applicant: HOECHST AG
Inventor: ENHSEN ALFONS , GLOMBIK HEINER , KRAMER WERNER , WESS GUENTHER
IPC: A61K31/575 , A61P3/06 , A61P9/00 , C07J3/00 , C07J7/00 , C07J9/00 , C07J31/00 , C07J41/00 , C07J51/00
Abstract: nor-Bile acid derivatives, processes for their preparation and the use of these compounds as medicaments nor-Bile acid derivatives of the formula I G1 - X - G2 I in which G1, G2 and X have the meanings given, processes for the preparation of these compounds and medicaments are described. On the basis of their pharmacological action, they can be used as an antihyperlipidemic agent.
-
-
-
-
-
-
-
-
-